Target intelligence / Profile preview

Plasmodium falciparum food vacuole membrane lipid interface

Molecular classification
Other
01

Overview

The Plasmodium falciparum food vacuole membrane lipid interface is a specialized microenvironment essential for the detoxification of heme during the parasite's erythrocytic cycle (Egan, 2008, Journal of Inorganic Biochemistry). As the parasite digests host hemoglobin within its acidic food vacuole, it releases large quantities of redox-active ferriprotoporphyrin IX (heme), which is toxic to the organism (Sullivan, 2002, International Journal for Parasitology). To survive, the parasite facilitates the biomineralization of heme into inert crystals known as hemozoin, a process catalyzed by lipids at the vacuolar membrane interface (Hempelmann, 2007, Pharmaceutical Reports). This site is the primary target for several classes of antimalarial drugs, most notably the quinolines such as chloroquine and amodiaquine. These drugs accumulate to high concentrations within the food vacuole and disrupt the crystallization process by binding to heme or the growing crystal surface at the lipid interface. The resulting accumulation of free heme leads to oxidative stress, membrane damage, and ultimately the death of the parasite. Despite the emergence of resistance mediated by membrane transporters like PfCRT, this interface remains a focal point for antimalarial drug discovery and development.

Other names
Heme crystallization siteHemozoin formation siteFood vacuole lipid-water interfaceDigestive vacuole membrane interfaceHeme detoxification site
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin by binding to ferriprotoporphyrin IX (heme) or the crystal surface at the lipid-water interface, leading to the accumulation of toxic free heme.

03

Biological functions

Heme detoxificationHemoglobin catabolismBiomineralization
04

Disease associations

Infection
05

Safety considerations

Widespread drug resistance (PfCRT/PfMDR1 mutations)Cardiotoxicity (QT prolongation)RetinopathyNeurotoxicity
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Plasmodium falciparum chloroquine resistance transporter (PfCRT) mutationsPlasmodium falciparum multidrug resistance protein 1 (PfMDR1) mutationsHemozoin pigment levels

Beyond the preview

Go deeper on Plasmodium falciparum food vacuole membrane lipid interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum food vacuole membrane lipid interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call